These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18401702)

  • 1. Poor usage of HUGO standard gene nomenclature in breast cancer studies.
    Lacroix M
    Breast Cancer Res Treat; 2009 Mar; 114(2):385-6. PubMed ID: 18401702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Breast cancer and molecular markers].
    Ishioka C
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1261-8. PubMed ID: 18701834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HUGO Gene Nomenclature Committee (HGNC).
    Povey S; Lovering R; Bruford E; Wright M; Lush M; Wain H
    Hum Genet; 2001 Dec; 109(6):678-80. PubMed ID: 11810281
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
    Behera RK; Nayak R
    Cancer Invest; 2009 Jun; 27(5):561-7. PubMed ID: 19219653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-10b and breast cancer metastasis.
    Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
    Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polymorphisms of tumor necrosis factor genes in sporadic and hereditary breast cancer].
    Malivanova TF; Ostashkin AS; Iurchenko VA; Mazurenko NN
    Vopr Onkol; 2007; 53(6):664-7. PubMed ID: 18416134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is triple-negative breast cancer?
    Irvin WJ; Carey LA
    Eur J Cancer; 2008 Dec; 44(18):2799-805. PubMed ID: 19008097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of breast cancer.
    Pandey A; Singh AK; Maurya SK; Rai R; Tewari M; Kumar M; Shukla HS
    J Surg Oncol; 2009 May; 99(6):386-92. PubMed ID: 19235775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor usage of HUGO standard gene nomenclature in cancer marker studies.
    Lacroix M
    Int J Biol Markers; 2008; 23(2):123-6. PubMed ID: 18629786
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
    Calabrò A; Beissbarth T; Kuner R; Stojanov M; Benner A; Asslaber M; Ploner F; Zatloukal K; Samonigg H; Poustka A; Sültmann H
    Breast Cancer Res Treat; 2009 Jul; 116(1):69-77. PubMed ID: 18592372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model.
    Rhee DK; Park SH; Jang YK
    Genomics; 2008 Dec; 92(6):419-28. PubMed ID: 18804527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human cancer genome project--one more misstep in the war on cancer.
    Gabor Miklos GL
    Nat Biotechnol; 2005 May; 23(5):535-7. PubMed ID: 15877064
    [No Abstract]   [Full Text] [Related]  

  • 16. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for human gene nomenclature].
    Wojcik F
    Ann Biol Clin (Paris); 2002; 60(3):347-50. PubMed ID: 12050054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human chromosome 3P regions of putative tumor-suppressor genes in renal, breast, and ovarian carcinomas].
    Loginov VI; Bazov IV; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Zbarovskiĭ ER; Braga EA
    Genetika; 2008 Feb; 44(2):250-6. PubMed ID: 18619045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of p16/INK4a gene damages and protein expression in the tumor tissue of sporadic breast cancer].
    Nemtsova MV; Zemliakova VV; Kuznetsova EV; Popova OP; Zavalishina LE; Frank GA; Zaletaev DV
    Arkh Patol; 2008; 70(4):6-9. PubMed ID: 18807517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
    Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
    Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.